| 臺大學術典藏 |
2020-08-13T07:22:35Z |
Improving visualization of intracranial arteries at the skull base for CT angiography with calcified plaques
|
Huang A.;Chung-Wei Lee;Yang C.-Y.;Liu H.-M.; Huang A.; CHUNG-WEI LEE; Yang C.-Y.; Liu H.-M. |
| 臺大學術典藏 |
2020-08-13T07:22:35Z |
Using standard nonenhanced axial scans for cerebral CT angiography bone elimination: Feasibility study
|
Huang A.;Chung-Wei Lee;Yang C.-Y.;Liu M.-Y.;Liu H.-M.; Huang A.; CHUNG-WEI LEE; Yang C.-Y.; Liu M.-Y.; Liu H.-M. |
| 臺大學術典藏 |
2020-08-13T07:22:35Z |
On concise 3-D simple point characterizations: A marching cubes paradigm
|
Huang A.; Liu H.-M.; CHUNG-WEI LEE; Yang C.-Y.; Tsang Y.-M. |
| 臺大學術典藏 |
2020-08-13T07:22:35Z |
Image of the month
|
Liu K.-L.; Yang C.-Y.; CHUNG-WEI LEE; Yuan R.-H. |
| 臺大學術典藏 |
2020-08-13T07:22:33Z |
CT angiography findings in carotid blowout syndrome and its role as a predictor of 1-year survival
|
Liu H.-M.; Wang Y.-H.; Huang A.; CHUNG-WEI LEE; Yang C.-Y.; Chen Y.-F. |
| 臺大學術典藏 |
2020-08-13T07:22:26Z |
Volume Visualization for Improving CT Lung Nodule Detection
|
Liu H.-M.; Yang C.-Y.; CHUNG-WEI LEE; Huang A.; Huang A.;Chung-Wei Lee;Yang C.-Y.;Liu H.-M. |
| 臺大學術典藏 |
2020-08-13T06:34:06Z |
The VEGF-C/Flt-4 axis promotes invasion and metastasis of cancer cells
|
Chou C.-H.; Jeng Y.-M.; Wang M.-Y.; Chang K.-J.; Hung M.-C.; Kuo M.-L.; Su J.-L.; Yang P.-C.; JIN-YUAN SHIH; Yang C.-Y.; Wei L.-H.; Hsieh C.-Y. |
| 臺大學術典藏 |
2020-08-13T06:34:05Z |
Retraction: Knockdown of contactin-1 expression suppresses invasion and metastasis of lung adenocarcinoma (Cancer Research (2006) 66 (2553–2561) DOI: 10.1158/0008-5472.CAN-05-2645)
|
Kuo M.-L.; JIN-YUAN SHIH; Wei L.-H.; Hsieh C.-Y.; Jeng Y.-M.; Wang M.-Y.; Yang P.-C.; Yang C.-Y.; Su J.-L. |
| 臺大學術典藏 |
2020-08-13T06:34:05Z |
Knockdown of contactin-1 expression suppresses invasion and metastasis of lung adenocarcinoma
|
Jeng Y.-M.; Wang M.-Y.; Yang P.-C.; Kuo M.-L.; Wei L.-H.; Hsieh C.-Y.; JIN-YUAN SHIH; Yang C.-Y.; Su J.-L. |
| 臺大學術典藏 |
2020-08-13T06:34:04Z |
The VEGF-C/Flt-4 Axis Promotes Invasion and Metastasis of Cancer Cells (DOI:10.1016/j.ccr.2006.02.018)
|
Kuo M.-L.; Hung M.-C.; Chang K.-J.; Wang M.-Y.; Jeng Y.-M.; Chou C.-H.; Hsieh C.-Y.; Wei L.-H.; Su J.-L.; Yang P.-C.; JIN-YUAN SHIH; Yang C.-Y. |
| 臺大學術典藏 |
2020-08-13T06:34:01Z |
The VEGF-C/Flt-4 Axis Promotes Invasion and Metastasis of Cancer Cells (DOI:10.1016/j.ccr.2006.02.018)
|
Chou C.-H.; Jeng Y.-M.; Wang M.-Y.; Chang K.-J.; Hung M.-C.; Kuo M.-L.; Hsieh C.-Y.; Wei L.-H.; Yang C.-Y.; Su J.-L.; Yang P.-C.; JIN-YUAN SHIH |
| 臺大學術典藏 |
2020-08-13T06:33:37Z |
Outcomes of cancer therapy administered to treatment-na?ve lung cancer patients in the intensive care unit
|
Lin J.-W.; Ho C.-C.; Yang C.-Y.; Chang C.-H.; Huang T.-M.; Chen C.-Y.; Chen K.-Y.; JIN-YUAN SHIH; Yu C.-J.; Chen Y.-F.; Chen Y.-F.;Lin J.-W.;Ho C.-C.;Yang C.-Y.;Chang C.-H.;Huang T.-M.;Chen C.-Y.;Chen K.-Y.;Jin-Yuan Shih;Yu C.-J. |
| 臺大學術典藏 |
2020-08-13T06:33:33Z |
Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan
|
Yang J.C.; Yu C.-J.; JIN-YUAN SHIH; Lin C.-C.; Tsai T.-H.; Hsu C.-L.; Hsu W.-H.; Su K.-Y.; Chang Y.-L.; Lee J.-H.; Chen K.-Y.; Liao W.-Y.; Lin S.-Y.;Yang C.-Y.;Liao B.-C.;Ho C.-C.;Liao W.-Y.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Hsu W.-H.;Su K.-Y.;Chang Y.-L.;Lee J.-H.;Lin C.-C.;Jin-Yuan Shih;Yang J.C.;Yu C.-J.; Lin S.-Y.; Yang C.-Y.; Liao B.-C.; Ho C.-C. |
| 臺大學術典藏 |
2020-08-13T06:33:28Z |
Consecutive emergence of typical acquired resistance to EGFR tyrosine kinase inhibitors in a patient with metastatic pulmonary squamous cell carcinoma
|
Yang C.-Y.; Hsieh M.-S.; Liao W.-Y.; JIN-YUAN SHIH; Yu C.-J. |
| 臺大學術典藏 |
2020-08-13T06:33:27Z |
A rare epidermal growth factor receptor H773L/V774M compound mutation in advanced non-small-cell lung cancer with poor response to epidermal growth factor receptor tyrosine kinase inhibitor
|
Yang C.-Y.; Yu C.-J.; JIN-YUAN SHIH; Chen L.-C.; Chen L.-C.;Jin-Yuan Shih;Yu C.-J.;Yang C.-Y. |
| 臺大學術典藏 |
2020-08-13T06:33:27Z |
Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations
|
Yang J.C.-H.; Yu C.-J.; JIN-YUAN SHIH; Lin Z.-Z.; Lin Y.-T.; Chen J.-S.; Liao W.-Y.; Ho C.-C.; Hsu C.-L.; Yang C.-Y.; Chen K.-Y.; Lee J.-H. |
| 臺大學術典藏 |
2020-08-13T06:33:24Z |
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
|
Tsai T.-H.; Chen K.-Y.; Ho C.-C.; Liao W.-Y.; Yang C.-Y.; Yang C.-Y.;Liao W.-Y.;Ho C.-C.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Su K.-Y.;Chang Y.-L.;Wu C.-T.;Hsu C.-C.;Liao B.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Jin-Yuan Shih;Yang J.C.-H.;Yu C.-J.; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; JIN-YUAN SHIH; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2020-08-13T06:33:24Z |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
Yu C.-J.; Yang J.C.-H.; JIN-YUAN SHIH; Lin C.-C.; Lee J.-H.; Hsu W.-H.; Liu Y.-N.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu C.-L.; Yang C.-Y.;Liao W.-Y.;Ho C.-C.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Liu Y.-N.;Su K.-Y.;Chang Y.-L.;Wu C.-T.;Liao B.-C.;Hsu C.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Jin-Yuan Shih;Yang J.C.-H.;Yu C.-J.; Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H. |
| 臺大學術典藏 |
2020-08-13T05:24:18Z |
Factors Associated with Lung Function Decline in Patients with Non-Tuberculous Mycobacterial Pulmonary Disease
|
Lee M.-R.; Yang C.-Y.; Chang K.-P.; Keng L.-T.; Yen D.H.-T.; JANN-YUAN WANG; Wu H.-D.; Lee L.-N.; Yu C.-J. |
| 臺大學術典藏 |
2020-08-13T05:24:15Z |
Multi-gene analyses from waste brushing specimens for patients with peripheral lung cancer receiving EBUS-assisted bronchoscopy
|
Yang C.-Y.; Tsai T.-H.; Ho C.-C.; Liao W.-Y.; Jan I.-S.; Chen K.-Y.; JANN-YUAN WANG; Ruan S.-Y.; Yu C.-J.; Yang J.C.H.; Yang P.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2020-08-13T05:24:09Z |
Effects of acute critical illnesses on the performance of interferon-gamma release assay
|
Huang C.-T.;Ruan S.-Y.;Tsai Y.-J.;Kuo P.-H.;Ku S.-C.;Lee P.-L.;Kuo L.-C.;Hsu C.-L.;Huang C.-K.;Yang C.-Y.;Chien Y.-C.;Jann-Yuan Wang;Yu C.-J.; Huang C.-T.; Ruan S.-Y.; Tsai Y.-J.; Kuo P.-H.; Ku S.-C.; Lee P.-L.; Kuo L.-C.; Hsu C.-L.; Huang C.-K.; Yang C.-Y.; Chien Y.-C.; JANN-YUAN WANG; Yu C.-J. |
| 臺大學術典藏 |
2020-08-12T07:57:23Z |
Cystic form of pulmonary sequestration
|
Sheng-Yuan Ruan ;Yang C.-Y. ;Yu C.-J.; SHENG-YUAN RUAN; Yang C.-Y.; Yu C.-J. |
| 臺大學術典藏 |
2020-08-12T07:57:21Z |
Multi-gene analyses from waste brushing specimens for patients with peripheral lung cancer receiving EBUS-assisted bronchoscopy
|
Tsai T.-H.; Yang C.-Y.; Ho C.-C.; Liao W.-Y.; Jan I.-S.; Chen K.-Y.; Wang J.-Y.; SHENG-YUAN RUAN; Yu C.-J.; Yang J.C.H.; Yang P.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2020-08-12T07:57:19Z |
Cautious application of pleural N-terminal pro-B-type natriuretic peptide in diagnosis of congestive heart failure pleural effusions among critically ill patients
|
Yeh J.-H.; Huang C.-T.; Liu C.-H.; SHENG-YUAN RUAN; Tsai Y.-J.; Chien Y.-C.; Yang C.-Y.; Huang C.-K.; Hsu C.-L.; Kuo L.-C.; Lee P.-L.; Ku S.-C.; Kuo P.-H.; Yu C.-J.; HINT Study Group |
| 臺大學術典藏 |
2020-08-12T07:57:17Z |
Effects of acute critical illnesses on the performance of interferon-gamma release assay
|
Huang C.-T.; SHENG-YUAN RUAN; Tsai Y.-J.; Kuo P.-H.; Ku S.-C.; Lee P.-L.; Kuo L.-C.; Hsu C.-L.; Huang C.-K.; Yang C.-Y.; Chien Y.-C.; Wang J.-Y.; Yu C.-J. |
| 臺大學術典藏 |
2020-08-12T06:34:43Z |
Current advances of endobronchial ultrasonography in the diagnosis and staging of lung cancer
|
Lin C.-K.; Yang C.-Y.; Chang L.-Y.; Lin S.-Y.; CHONG-JEN YU; Ho C.-C.; Ho C.-C.;Lin C.-K.;Yang C.-Y.;Chang L.-Y.;Lin S.-Y.;Chong-Jen Yu |
| 臺大學術典藏 |
2020-08-12T06:34:19Z |
A rare epidermal growth factor receptor H773L/V774M compound mutation in advanced non-small-cell lung cancer with poor response to epidermal growth factor receptor tyrosine kinase inhibitor
|
Yang C.-Y.; CHONG-JEN YU; Chen L.-C.;Shih J.-Y.;Chong-Jen Yu;Yang C.-Y.; Chen L.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2020-08-12T06:34:19Z |
Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations
|
Lin Y.-T.;Chen J.-S.;Liao W.-Y.;Ho C.-C.;Hsu C.-L.;Yang C.-Y.;Chen K.-Y.;Lee J.-H.;Lin Z.-Z.;Shih J.-Y.;Yang J.C.-H.;Chong-Jen Yu; Ho C.-C.; Hsu C.-L.; Yang C.-Y.; Chen K.-Y.; Lee J.-H.; Lin Z.-Z.; Shih J.-Y.; Yang J.C.-H.; CHONG-JEN YU; Lin Y.-T.; Chen J.-S.; Liao W.-Y. |
| 臺大學術典藏 |
2020-08-12T06:34:15Z |
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
|
Hsu C.-C.; Wu C.-T.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; Yang C.-Y.; Yang C.-Y.;Liao W.-Y.;Ho C.-C.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Su K.-Y.;Chang Y.-L.;Wu C.-T.;Hsu C.-C.;Liao B.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.-H.;Chong-Jen Yu; Liao B.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; CHONG-JEN YU |
| 臺大學術典藏 |
2020-08-12T05:14:11Z |
Effects of acute critical illnesses on the performance of interferon-gamma release assay
|
Huang C.-T.;Ruan S.-Y.;Tsai Y.-J.;Kuo P.-H.;Ku S.-C.;Lee P.-L.;Kuo L.-C.;Hsu C.-L.;Huang C.-K.;Yang C.-Y.;Ying-Chun Chien;Wang J.-Y.;Yu C.-J.; Huang C.-T.; Ruan S.-Y.; Tsai Y.-J.; Kuo P.-H.; Ku S.-C.; Lee P.-L.; Kuo L.-C.; Hsu C.-L.; Huang C.-K.; Yang C.-Y.; YING-CHUN CHIEN; Wang J.-Y.; Yu C.-J. |
| 臺大學術典藏 |
2020-08-12T02:50:43Z |
Outcomes of cancer therapy administered to treatment-na?ve lung cancer patients in the intensive care unit
|
Yu C.-J.; Shih J.-Y.; Chen Y.-F.; Lin J.-W.; CHAO-CHI HO; Yang C.-Y.; Chang C.-H.; Huang T.-M.; Chen C.-Y.; Chen K.-Y.; Chen Y.-F.;Lin J.-W.;Chao-Chi Ho;Yang C.-Y.;Chang C.-H.;Huang T.-M.;Chen C.-Y.;Chen K.-Y.;Shih J.-Y.;Yu C.-J. |
| 臺大學術典藏 |
2020-08-12T02:50:41Z |
Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan
|
Lin S.-Y.;Yang C.-Y.;Liao B.-C.;Chao-Chi Ho;Liao W.-Y.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Hsu W.-H.;Su K.-Y.;Chang Y.-L.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.;Yu C.-J.; Lin S.-Y.; Yang C.-Y.; Liao B.-C.; CHAO-CHI HO; Liao W.-Y.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Hsu W.-H.; Su K.-Y.; Chang Y.-L.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.; Yu C.-J. |
| 臺大學術典藏 |
2020-08-12T02:50:37Z |
Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations
|
Yu C.-J.; Yang C.-Y.; Chen K.-Y.; Lee J.-H.; Lin Z.-Z.; Shih J.-Y.; Yang J.C.-H.; Hsu C.-L.; CHAO-CHI HO; Liao W.-Y.; Chen J.-S.; Lin Y.-T.; Lin Y.-T.;Chen J.-S.;Liao W.-Y.;Chao-Chi Ho;Hsu C.-L.;Yang C.-Y.;Chen K.-Y.;Lee J.-H.;Lin Z.-Z.;Shih J.-Y.;Yang J.C.-H.;Yu C.-J. |
| 臺大學術典藏 |
2020-08-12T02:50:36Z |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.; Wu C.-T.; Chang Y.-L.; Yang C.-Y.;Liao W.-Y.;Chao-Chi Ho;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Liu Y.-N.;Su K.-Y.;Chang Y.-L.;Wu C.-T.;Liao B.-C.;Hsu C.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.-H.;Yu C.-J.; Yang C.-Y.; Liao W.-Y.; CHAO-CHI HO; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y. |
| 臺大學術典藏 |
2020-08-12T02:50:35Z |
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
|
Yang C.-Y.;Liao W.-Y.;Chao-Chi Ho;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Su K.-Y.;Chang Y.-L.;Wu C.-T.;Hsu C.-C.;Liao B.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.-H.;Yu C.-J.; Yang C.-Y.; Liao W.-Y.; CHAO-CHI HO; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2020-08-11T08:36:50Z |
Human cationic trypsinogen but not serine peptidase inhibitor, Kazal type 1 variants increase the risk of type 1 autoimmune pancreatitis
|
Jeng Y.-M.; Yang C.-Y.; Tien Y.-W.; Wong J.-M.; Chang Y.-T.; PO-CHIN LIANG; Jan I.-S.; Chang M.-C. |
| 臺大學術典藏 |
2020-08-11T08:36:50Z |
Comparison and validation of International Consensus Diagnostic Criteria for diagnosis of autoimmune pancreatitis from pancreatic cancer in a Taiwanese cohort
|
Chang M.-C.; PO-CHIN LIANG; Jan I.-S.; Yang C.-Y.; Tien Y.-W.; Wei S.-C.; Wong J.-M.; Chang Y.-T. |
| 臺大學術典藏 |
2020-08-11T08:36:47Z |
Overweight Increases the Risk of Malignancy in Patients with Pancreatic Mucinous Cystic Neoplasms
|
Chang Y.-T.; Tien Y.-W.; Jeng Y.-M.; Yang C.-Y.; PO-CHIN LIANG; Wong J.-M.; Chang M.-C. |
| 臺大學術典藏 |
2020-08-11T08:36:47Z |
Increase diagnostic accuracy in differentiating focal type autoimmune pancreatitis from pancreatic cancer with combined serum IgG4 and CA19-9 levels
|
Chang M.-C.; PO-CHIN LIANG; Jan S.; Yang C.-Y.; Tien Y.-W.; Wei S.-C.; Wong J.-M.; Chang Y.-T. |
| 臺大學術典藏 |
2020-08-11T08:36:46Z |
Cystic fibrosis transmembrane conductance regulator gene variants are associated with autoimmune pancreatitis and slow response to steroid treatment
|
Chang M.-C.; Jan I.-S.; PO-CHIN LIANG; Jeng Y.-M.; Yang C.-Y.; Tien Y.-W.; Wong J.-M.; Chang Y.-T. |
| 臺大學術典藏 |
2020-08-07T02:32:14Z |
Validation of Indications for Surgery of European Evidence-Based Guidelines for Patients with Pancreatic Intraductal Papillary Mucinous Neoplasms
|
Jan I.S.;Chang M.C.;Yang C.Y.;Tien Y.W.;Jeng Y.M.;Chih-Horng Wu;Chen B.-B.;Chang Y.T.; Jan I.S.; Chang M.C.; Yang C.Y.; Tien Y.W.; Jeng Y.M.; CHIH-HORNG WU; Chen B.-B.; Chang Y.T. |
| 臺大學術典藏 |
2020-08-05T02:46:31Z |
Establishing a web-based DICOM teaching file authoring tool using open-source public software
|
WEN-JENG LEE; Yang C.-Y.; Liu K.-L.; Liu H.-M.; Ching Y.-T.; Chen S.-J.; Wen-Jeng Lee;Yang C.-Y.;Liu K.-L.;Liu H.-M.;Ching Y.-T.;Chen S.-J. |
| 臺大學術典藏 |
2020-08-05T02:46:25Z |
A preliminary study of medical image distributed intelligent access integrated with electronic medical records system for brain degenerative disease
|
Liu H.-M.; Yip P.-K.; Chen H.-S.; Yang C.-Y.; Chen S.-J.; WEN-JENG LEE; Cheng P.-H.; Su M.-J.; Lai F.-P.; Racoceanu D. |
| 臺大學術典藏 |
2020-07-21T06:46:30Z |
CNS infections caused by Mycobacterium abscessus complex: clinical features and antimicrobial susceptibilities of isolates
|
Lee M.-R.; Cheng A.; Lee Y.-C.; Yang C.-Y.; Lai C.-C.; Huang Y.-T.; CHAO-CHI HO; Wang H.-C.; Yu C.-J.; Hsueh P.-R. |
| 臺大學術典藏 |
2020-07-21T06:46:29Z |
Multi-gene analyses from waste brushing specimens for patients with peripheral lung cancer receiving EBUS-assisted bronchoscopy
|
Shih J.-Y.; Ruan S.-Y.; Wang J.-Y.; Tsai T.-H.; Yang C.-Y.; CHAO-CHI HO; Liao W.-Y.; Jan I.-S.; Chen K.-Y.; Yang P.-C.; Yang J.C.H.; Yu C.-J. |
| 臺大學術典藏 |
2020-07-21T06:46:26Z |
Current advances of endobronchial ultrasonography in the diagnosis and staging of lung cancer
|
Lin S.-Y.; Yu C.-J.; CHAO-CHI HO; Lin C.-K.; Yang C.-Y.; Chang L.-Y. |
| 臺大學術典藏 |
2020-07-21T06:46:23Z |
Outcomes of cancer therapy administered to treatment-na?ve lung cancer patients in the intensive care unit
|
Chen Y.-F.; Lin J.-W.; CHAO-CHI HO; Yang C.-Y.; Chang C.-H.; Huang T.-M.; Chen C.-Y.; Chen K.-Y.; Shih J.-Y.; Yu C.-J. |
| 臺大學術典藏 |
2020-07-21T06:46:21Z |
Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan
|
Lin C.-C.; Lee J.-H.; Chang Y.-L.; Su K.-Y.; Hsu W.-H.; Hsu C.-L.; Tsai T.-H.; Chen K.-Y.; Lin S.-Y.; Yang C.-Y.; Liao B.-C.; CHAO-CHI HO; Liao W.-Y.; Yu C.-J.; Yang J.C.; Shih J.-Y. |
| 臺大學術典藏 |
2020-07-21T06:46:16Z |
Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations
|
Lin Y.-T.; Chen J.-S.; Liao W.-Y.; CHAO-CHI HO; Hsu C.-L.; Yang C.-Y.; Chen K.-Y.; Lee J.-H.; Lin Z.-Z.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2020-07-21T06:46:15Z |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.; Chang Y.-L.; Su K.-Y.; Hsu C.-L.; Liu Y.-N.; Chen K.-Y.; Tsai T.-H.; Liao W.-Y.; CHAO-CHI HO; Yang C.-Y. |
